(Q37865171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

RANKL inhibition: a promising novel strategy for breast cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Eva González-Suárez

series ordinal

1

1 reference

24 August 2017

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

222-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-011-0646-5

28 January 2020

exact match

0 references

cites work

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Molecular therapy of breast cancer: progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANKL-RANK signaling in osteoclastogenesis and bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Mitogen-activated protein kinases in apoptosis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

The PI3K-PDK1 connection: more than just a road to PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK/RANKL: regulators of immune responses and bone physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Physiology and pathophysiology of the RANKL/RANK system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Novel functions of RANK(L) signaling in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK-L and RANK: T cells, bone loss, and mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Generation of a functional mammary gland from a single stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Control of mammary stem cell function by steroid hormone signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Progesterone induces adult mammary stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Transcriptional response of the murine mammary gland to acute progesterone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Insights into the cell of origin in breast cancer and breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0646-5

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

21 January 2018

1 reference

12 December 2020

Reproductive factors and breast cancer

1 reference

12 December 2020

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast

1 reference

12 December 2020

Purification and unique properties of mammary epithelial stem cells

1 reference

12 December 2020

Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma

1 reference

12 December 2020

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

1 reference

12 December 2020

10.1007/S12094-011-0646-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21493182%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference